These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33682142)

  • 21. Fetal fraction and noninvasive prenatal testing: What clinicians need to know.
    Hui L; Bianchi DW
    Prenat Diagn; 2020 Jan; 40(2):155-163. PubMed ID: 31821597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-free DNA screening for fetal aneuploidy using the rolling circle method: A step towards non invasive prenatal testing simplification.
    Pavanello E; Sciarrone A; Guaraldo V; Muccinelli E; Ciuffreda VP; Sauro P; Bondielli G; Mirante S; Mengozzi G; Viora E; Cuckle H; Pasini B
    Prenat Diagn; 2021 Dec; 41(13):1694-1700. PubMed ID: 34569636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Causes of aberrant non-invasive prenatal testing for aneuploidy: A systematic review.
    Samura O; Okamoto A
    Taiwan J Obstet Gynecol; 2020 Jan; 59(1):16-20. PubMed ID: 32039788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low fetal fraction in cell-free DNA testing is associated with adverse pregnancy outcome: Analysis of a subcohort of the TRIDENT-2 study.
    Becking EC; Wirjosoekarto SAM; Scheffer PG; Huiskes JVM; Remmelink MJ; Sistermans EA; Bax CJ; Weiss JM; Henneman L; Bekker MN
    Prenat Diagn; 2021 Sep; 41(10):1296-1304. PubMed ID: 34426993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical experience across the fetal-fraction spectrum of a non-invasive prenatal screening approach with low test-failure rate.
    Hancock S; Ben-Shachar R; Adusei C; Oyolu CB; Evans EA; Kang HP; Haverty C; Muzzey D
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):422-430. PubMed ID: 31671482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low fetal fraction in obese women at first trimester cell-free DNA based prenatal screening is not accompanied by differences in total cell-free DNA.
    Shree R; Kolarova TR; MacKinnon HJ; Hedge JM; Vinopal E; Ma KK; Lockwood CM; Chandrasekaran S
    Prenat Diagn; 2021 Sep; 41(10):1277-1286. PubMed ID: 34297415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fetal fraction of cell-free DNA in pregnancies after fresh or frozen embryo transfer following assisted reproductive technologies.
    Talbot AL; Ambye L; Hartwig TS; Werge L; Sørensen S; Stormlund S; Prætorius L; Jørgensen HL; Pinborg A; Jørgensen FS
    Hum Reprod; 2020 Jun; 35(6):1267-1275. PubMed ID: 32539141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective analysis the clinic data and follow-up of non-invasive prenatal test in detection of fetal chromosomal aneuploidy in more than 40,000 cases in a single prenatal diagnosis center.
    Luo Y; Hu H; Jiang L; Ma Y; Zhang R; Xu J; Pan Y; Long Y; Yao H; Liang Z
    Eur J Med Genet; 2020 Sep; 63(9):104001. PubMed ID: 32622960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into non-informative results from non-invasive prenatal screening through gestational age, maternal BMI, and age analyses.
    Gazdarica J; Forgacova N; Sladecek T; Kucharik M; Budis J; Hyblova M; Sekelska M; Gnip A; Minarik G; Szemes T
    PLoS One; 2024; 19(3):e0280858. PubMed ID: 38452118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.
    Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT
    Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of preexamination conditions in a centralized-testing model of non-invasive prenatal screening.
    Fibke C; Giroux S; Caron A; Starks E; Parker JDK; Swanson L; Jouan L; Langlois S; Rouleau G; Rousseau F; Karsan A
    Clin Chem Lab Med; 2022 Jan; 60(2):183-190. PubMed ID: 34761647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower fetal fraction in clinical cell-free DNA screening results is associated with increased risk of hypertensive disorders of pregnancy.
    Madala D; Maktabi MA; Sabbagh R; Erfani H; Moon A; Van den Veyver IB
    Prenat Diagn; 2022 Sep; 42(10):1253-1261. PubMed ID: 35943975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 2-year review of publicly funded cell-free DNA screening in Ontario: utilization and adherence to funding criteria.
    Bellai-Dussault K; Meng L; Huang T; Reszel J; Walker M; Lanes A; Okun N; Armour C; Dougan S
    Prenat Diagn; 2020 Jan; 40(2):164-172. PubMed ID: 31525278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune disorders but not heparin are associated with cell-free fetal DNA test failure.
    Dabi Y; Guterman S; Jani JC; Letourneau A; Demain A; Kleinfinger P; Lohmann L; Costa JM; Benachi A
    J Transl Med; 2018 Dec; 16(1):335. PubMed ID: 30509296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting cell-free DNA fetal fraction and the consequences for test accuracy.
    Scott FP; Menezes M; Palma-Dias R; Nisbet D; Schluter P; da Silva Costa F; McLennan AC
    J Matern Fetal Neonatal Med; 2018 Jul; 31(14):1865-1872. PubMed ID: 28514925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Reference Materials for Noninvasive Prenatal Aneuploidy Testing by Massively Parallel Sequencing: A Proof-of-Concept Study.
    Blais J; Giroux S; Caron A; Clément V; Rousseau F
    J Appl Lab Med; 2019 Jul; 4(1):50-60. PubMed ID: 31639707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low Fetal Fraction and Birth Weight in Women with Negative First-Trimester Cell-Free DNA Screening.
    Clapp MA; Berry M; Shook LL; Roberts PS; Goldfarb IT; Bernstein SN
    Am J Perinatol; 2020 Jan; 37(1):86-91. PubMed ID: 31739367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonreportable rates and cell-free DNA profiles in noninvasive prenatal testing among women with heparin treatment.
    Nakamura N; Sasaki A; Mikami M; Nishiyama M; Akaishi R; Wada S; Ozawa N; Sago H
    Prenat Diagn; 2020 Jun; 40(7):838-845. PubMed ID: 32274797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishing and validating noninvasive prenatal testing procedure for fetal aneuploidies in Vietnam.
    Phan MD; Nguyen TV; Trinh HNT; Vo BT; Nguyen TM; Nguyen NH; Nguyen TTQ; Do TTT; Hoang TTD; Truong KD; Giang H; Nguyen HN
    J Matern Fetal Neonatal Med; 2019 Dec; 32(23):4009-4015. PubMed ID: 29865915
    [No Abstract]   [Full Text] [Related]  

  • 40. State-wide utilization and performance of traditional and cell-free DNA-based prenatal testing pathways: the Victorian Perinatal Record Linkage (PeRL) study.
    Lindquist A; Hui L; Poulton A; Kluckow E; Hutchinson B; Pertile MD; Bonacquisto L; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; Da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
    Ultrasound Obstet Gynecol; 2020 Aug; 56(2):215-224. PubMed ID: 31625225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.